Clinical trial
Progressive Ventricular Dysfunction Prevention in Pacemaker Patients
NCT00170326 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00170326 |
|---|---|
| Title | Progressive Ventricular Dysfunction Prevention in Pacemaker Patients |
| Official title | Progressive Ventricular Dysfunction Prevention in Pacemaker Patients |
| Acronym | Prevent-HF |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiac Pacing Indication classI/IIa According AHA/ACC |
| Intervention type | Procedure |
| Interventions | dual-chamber pacemaker implantation, biventricular dual-chamber pacemaker implant |
| Enrollment | 108 |
| Start date | Jan 1, 2002 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 3, 2025 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: